AZD7442 Antibody and Bivalent COVID-19 Vaccine Are Well Tolerated in Immunocompromised Adults
A multicentre phase II trial found that co-administering the monoclonal antibody AZD7442 and a bivalent vaccine was well tolerated in ...
A multicentre phase II trial found that co-administering the monoclonal antibody AZD7442 and a bivalent vaccine was well tolerated in ...
Researchers designed three lipid nanoparticle mRNA vaccines targeting swine influenza hemagglutinin, finding that a swine-to-human antigen induced the broadest cross-reactive ...
A scientific review in Discover Nano highlights the therapeutic progress and ongoing translational hurdles facing lipid nanoparticle-mediated mRNA delivery systems ...
The National Institutes of Health has awarded a five-year, $57.5 million grant to Boston University's National Emerging Infectious Diseases Laboratories ...
A comprehensive review details how microneedle patches integrate solid-state stabilization, skin-targeted delivery, programmable booster dosing, and on-patient optical documentation into ...
A comprehensive review analyzes how microneedle arrays overcome biological barriers to deliver nucleic acids and gene-editing platforms directly into local ...
A new review synthesizes evidence that gut microbiota composition and metabolites such as short-chain fatty acids modulate immune responses to ...
A new review outlines how universal influenza vaccine platforms, from mRNA and viral vectors to adjuvanted inactivated vaccines, could broaden ...
A new review finds that mRNA vaccines and host-directed therapeutics for multidrug-resistant ESKAPE bacteria remain preclinical, with no licensed bacterial ...
An AI-guided lipid nanoparticle formulation remained functional after two months at 37 degrees Celsius or one year at room temperature ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine